Skip to content
OpenCapital
Get started

Journey Medical Corporation DERM Q1 2026 earnings

Reported May 13, 2026 · After market close

Revenue$16.0MBeat by $488.3KDiluted EPS-$0.08Miss by $0.01
Revenue estimate$15.5M
EPS estimate-$0.07

Next report

Aug 11, 2026 (in a month)
Revenue estimate$18.4M
EPS estimate-$0.01

Financials

Q1 2026

Income statement

See full
Revenue$16.0M+21.5%
Gross profit$9.7M+16.7%
Operating income-$1.5M+55.1%
Net income-$2.2M+45.2%
EPS (diluted)-$0.08+55.6%

Balance sheet

See full
Cash & equivalents$27.2M+29.2%
Total debt$25.5M+1.2%
Total equity$30.8M+43.1%
Total assets$91.5M+7.7%

Cash flow

See full
Operating cash flow$2.9M+203%

Valuation & ratios

Valuation

as of 07/10/26
See full
Market cap$192.74M-6.0%
Enterprise value$190.99M-10.0%
P/S3×-0.7×

Profitability

See full
Gross margin65.4%-1.0pp
Operating margin-9.8%—
Net margin-14.8%—

Returns & leverage

See full
Return on equity-36.6%—
Debt / equity0.8×-0.3×
Current ratio1.7×+0.4×

Segments

By product

See full
Emrosi$6.3M+202%
Qbrexza$5.0M-2.6%
Accutane$3.3M-9.3%
Foam Franchise Products Amzeeq Zilxi$1.1M—
Other Legacy$277.0K-61.9%

By segment

See full
Dermatological$16.0M+21.5%

Versus estimates

Revenue

Q1 2026$16.0MBeat by $488.3K
Q4 2025$16.1MMiss by $2.8MQ3 2025$17.6MMiss by $1.2MQ2 2025$15.0MMiss by $3.9MQ1 2025$13.1MMiss by $1.8MQ4 2024$13.6MBeat by $1.6M

Diluted EPS

Q1 2026-$0.08Miss by $0.01
Q4 2025-$0.04Beat by $0.02Q3 2025-$0.09Miss by $0.01Q2 2025-$0.16Miss by $0.09Q1 2025-$0.18Beat by $0.06Q4 2024$0.08Beat by $0.30

Ask the moment Journey Medical Corporation reports.

Connect your AI and ask the moment the filing drops. It reads the release, surfaces what management said, and gives you its own read.

Connect your AI
Harbor at dusk
Claude

Questions, answered.

When did Journey Medical Corporation report Q1 2026 earnings?
Journey Medical Corporation (DERM) reported Q1 2026 earnings on May 13, 2026 after market close.
What were Journey Medical Corporation's Q1 2026 revenue and EPS?
Journey Medical Corporation reported revenue of $16.0M and diluted EPS of $-0.08 for Q1 2026.
Did Journey Medical Corporation beat estimates in Q1 2026?
Revenue beat the consensus estimate of $15.5M by $488.3K. EPS missed the consensus estimate of $-0.07 by $0.01.
How did Journey Medical Corporation's Q1 2026 results compare year-over-year?
Compared to the same quarter a year prior, revenue grew 21.5% from $13.1M a year earlier and diluted EPS grew 55.6% from $-0.18.
Where can I find Journey Medical Corporation's Q1 2026 SEC filings?
You can read the 8-K earnings release (0001104659-26-060232) and the 10-Q periodic report (0001104659-26-060297) directly on SEC EDGAR. The filing index links above go to sec.gov.